The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,246.00
Bid: 12,254.00
Ask: 12,256.00
Change: -72.00 (-0.58%)
Spread: 2.00 (0.016%)
Open: 12,324.00
High: 12,406.00
Low: 12,246.00
Prev. Close: 12,318.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

Mon, 29th Apr 2024 10:02

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

----------

FTSE 100

----------

Deutsche Bank raises Experian target to 3,500 (2,918) pence - 'hold'

----------

Deutsche Bank starts JD Sports with 'hold' - price target 115 pence

----------

Barclays cuts JD Sports to 'equal weight' - price target 140 pence

----------

Deutsche Bank starts Frasers with 'buy' - price target 1,000 pence

----------

RBC raises AB Foods price target to 2,900 (2,700) pence - 'outperform'

----------

Barclays raises Unilever price target to 5,000 (4,600) pence - 'overweight'

----------

DZ Bank raises AstraZeneca price target to 12,200 (10,400) pence - 'hold'

----------

Barclays raises Beazley price target to 910 (790) pence - 'overweight'

----------

UBS raises NatWest price target to 340 (315) pence - 'buy'

----------

Berenberg raises NatWest price target to 350 (325) pence - 'buy'

----------

JPMorgan raises NatWest price target to 350 (330) pence - 'overweight'

----------

RBC raises NatWest price target to 355 (340) pence - 'sector perform'

----------

Bank of America raises NatWest price target to 335 (320) pence - 'buy'

----------

RBC raises Barclays price target to 260 (255) pence - 'outperform'

----------

Bank of America cuts London Stock Exchange price target to 10,700 (11,100) pence - 'buy'

----------

FTSE 250

----------

Deutsche Bank starts Watches of Switzerland with 'hold' - price target 370 pence

----------

Deutsche Bank starts Moonpig with 'hold' - price target 180 pence

----------

Deutsche Bank starts Dr Martens with 'hold' - price target 65 pence

----------

Deutsche Bank starts Currys with 'hold' - price target 58 pence

----------

Deutsche Bank starts AO World with 'buy' - price target 120 pence

----------

Barclays raises Lancashire price target to 790 (770) pence - 'equal weight'

----------

Barclays raises Hiscox price target to 1,340 (1,190) pence - 'equal weight'

----------

RBC cuts WH Smith price target to 1,500 (1,600) pence - 'outperform'

----------

HSBC reinitiates Serco with 'buy' - price target 210 pence

----------

SMALL CAP, AIM AND OTHER MAIN MARKET

----------

Deutsche Bank starts Motorpoint with 'buy' - price target 170 pence

----------

Deutsche Bank starts boohoo with 'sell' - price target 27 pence

----------

Deutsche Bank starts Mothercare with 'buy' - price target 12 pence

----------

Goldman Sachs raises Just Eat Takeaway price target to 16 (15.80) EUR - 'neutral'

----------

Peel Hunt raises Sabre Insurance to 'buy' - price target 210 pence

----------

Jefferies cuts AB Dynamics price target to 1,490 (1,500) pence - 'underperform'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All rights reserved.

More News
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.